Regeneron Releases Positive Trial Data For Covid Antibody Treatment As It Seeks Emergency FDA AuthorizationForbes • 10/28/20
Regeneron's COVID-19 Outpatient Trial Prospectively Demonstrates that REGN-COV2 Antibody Cocktail Significantly Reduced Virus Levels and Need for Further Medical AttentionPRNewsWire • 10/28/20
Were Hedge Funds Right About Embracing Regeneron Pharmaceuticals Inc (REGN)?Insider Monkey • 10/26/20
Scott+Scott Attorneys at Law LLP Continues to Investigate Regeneron Pharmaceuticals, Inc.'s Directors and Officers for Breach of Fiduciary Duty (REGN)Business Wire • 10/21/20
Xera Med Research Is Making Advances In Assisting Regeneron In Their Antibodies Cocktail Clinical Trials Participation With Upwards Of 30 Patients To DatePRNewsWire • 10/21/20
How Monoclonal Antibodies Can Treat COVID-19 and What the Data Says About VaccinesThe Motley Fool • 10/20/20
How Regeneron's Coronavirus Antibody Treatment Differs From Convalescent PlasmaThe Motley Fool • 10/19/20
Regeneron's (REGN) Dupixent Gets Positive CHMP Opinion for DermatitisZacks Investment Research • 10/19/20
Regeneron Reports Positive Data, And Other News: The Good, Bad And Ugly Of BiopharmaSeeking Alpha • 10/15/20
Regeneron's Antibody Cocktail REGN-EB3 (Inmazeb®) is First FDA-Approved Treatment for Ebola (Zaire Ebolavirus)PRNewsWire • 10/14/20
Sanofi, Regeneron Report Positive Phase 3 Results For Asthma Drug Dupixent's Use In ChildrenBenzinga • 10/13/20